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  Abstract 
Tissue engineering and regenerative medicine are emerging as future approaches for the treatment 
of acute and chronic diseases. However, many challenging clinical conditions exist today and 
include congenital disorders, trauma, infection, inflammation and cancer, in which hard and soft 
tissue damage, organ failure and loss are still not treated effectively. Regenerative medicine has 
contributed to a number of innovations through artificial implants and biomedical materials, with 
advances are continually being made. Researchers are constantly developing new biomaterials and 
tissue engineered technologies to stimulate tissue regeneration in order to repair and replace 
damaged or malfunctioning organs. However, the challenge continues to lie in devising effective 
biomedical materials that can be implanted as scaffolds. Various approaches are emerging, 
according to the organ, tissue, disease and disorder. Scaffolds are implanted cell-free, or 
incorporated with stems cells, committed cells, or bioactive molecules. Irrespective, engineered 
biomaterials are required to regenerate and ultimately reproduce the original physiological, 
biological, chemical and mechanical properties over time. This is enabled by providing a three-
dimensional architecture for cells to adhere, migrate, proliferate within, and differentiate 
appropriately for the growth of new tissues to provide a relevant structure, and in so doing, restore 
function. Biodegradable materials have been used extensively as regenerative therapies since their 
advent in early 20th century. One notable example is the development of surgical fixation devices. 
The selection, design and physicochemical properties of these materials are important and must 
consider biocompatibility, biodegradability and minimal cytotoxicity in the host to enable cell-
proliferation, cell-matrix interactions and intercellular signalling for stimulating tissue growth.  
In this review, we critique the most studied and recently developed biodegradable polymers with 
the aim of highlighting recent trends and developments for targeting organ and tissue regeneration. 
Tissues and organs considered include the skin, nerves, blood vessels, heart, cornea, bone, dental 
and oral structure, trachea cavity. The limitations and future challenges of naturally occurring and 
bio mimetic tissue-engineered materials are also discussed.  
Key words: Biodegradable Polymers; Skin; Heart; Vascular Arteries; Dental Regeneration; Bone, 
Cornea 
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1. Introduction 
  Regenerative nanomedicine has been widely accepted which has an objective to 
develop the compatible biomaterials to interact with cells/tissues present in the site of 
implantation1-3. Tissue engineering and regenerative medicine exploits properties taken from the 
life sciences, engineering and physical sciences4-10, and is therefore not only a highly 
interdisciplinary field of research, but in practice comprised of many novel and speciality areas11. 
Humans in their life time, experience a number of acute diseases and traumas that affect cells, 
tissues and organs4, 6, which leads to the degeneration of living cells and tissues, or the 
malfunctioning of an entire organ system7. Physicians traditionally prescribe drug therapies to 
induce tissue regeneration, but there are occasions when organ transplantation is the only option. 
Organ replacement is constrained by two reasons ± firstly, artificial substitutes are not usually as 
effective or as long lasting when compared to the original tissue, and secondly organ donation and 
transplantation is highly reliant on a limited donor supply. The success of organ donation is also 
complicated by the potential of disease transmission or mismatching or rejection of the donor 
tissue. In this situation, there is utmost demand of developing biological substitutes via different 
chemical and biological strategies12, 13. Within this review, we discuss recently developed 
innovative and well experimented biodegradable materials that address the aforementioned 
hindrances. Furthermore, we highlight recent trends and achievements accomplished in organ or 
tissue regeneration research. Tissues and organs considered for this purpose include the skin, 
cornea, nerves, blood vessels, heart, trachea, bone, dental and oral cavity. The limitations and 
future challenges of naturally occurring and biomimetic tissue-engineered materials are also 
discussed. 
 
2. Tissue Engineering and regenerative medicine      
In tissue engineering, biomedical substitutes as biomaterials are continually being developed that 
completely (or partly) replace damaged tissue. An essential role for bio mimetic materials is to 
provide a 3-dimensional matrix as a scaffold. The materials must also be permissive for ensuring 
the maintenance of cells and signals for regenerating the particular tissue or organ14-16. 
Regenerated tissues must reinstate, maintain and augment function thereafter. Numerous 
biomaterials have been used as alternative treatments for damaged tissues or dysfunctional organs, 
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with the healing of fractured bones being a key example. The physical, chemical and biological 
properties of biomaterials can be tuned depending upon the organ in question and biological 
environment of the host cells or tissue. Tissue engineered materials may be functional at the time 
of implantation, or have the ability to integrate and form the expected function after implantation 
in the host. In either case the biomaterial must integrate favourable with transplanted or recipient 
cells in order to play a key role for tissue regeneration through cell-cell signalling, production of 
growth factors, proliferation, differentiation and the formation of an extracellular matrix (ECM)17-
22
.  
A number of studies have been conducted in the last few decades for developing new and improved 
bio-mimetic materials for a wide range of biomedical applications23-26. Developing physiologically 
functional artificial tissues and organs is a pre-requisite of tissue engineering, and technological 
developments in tissue engineering continually underpin progress. One of the earliest approaches, 
that of cell-seeded scaffolds has led to the current advances, which include new materials and 
methods of fabrication resulting into well-engineered biocompatible systems15. In addition, nano-
structuring of biomaterial scaffolds from nanoparticles, nanocomposites and organic-inorganic 
hybrid polymer materials have showed progress in organ regeneration. Various synthetic and 
natural polymers and their composite materials have been used to fabricate scaffolds for bone 
tissue engineering, nerve regeneration, controlled drug release, tooth structure regeneration, 
guided tissue regeneration, reinforcement of dental composite, bone and cartilage regeneration27. 
Moreover, micro fabrication technologies, such as lithography28, bio printing29, 30, micro 
moulding31 or photolithography32 are now becoming more routine and are emerging as powerful 
tools for the manufacture of biomaterials and tissue engineered constructs. Use of these micro and 
nanotechnologies not only replicates cell-scale complexities by providing the cells with a 
microenvironment that mimics the native structure, but also allows obtaining 3D architectures15, 
33-36
.  The advances in biomaterials science is also complimented with progresses in cell and 
molecular biology, in particular induced pluripotent stem cells which makes tissue engineering a 
highly multi-disciplinary discipline.  The challenge however is whether this promise will fulfil the 
long awaited desire of having readily available methods and facile approaches for regenerating 
tissues and organs14. 
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2.1- Biomaterials in Tissue Engineering 
During recent years, developments in tissue engineering, regenerative medicine, gene therapy, and 
controlled drug delivery have placed demand on the need for better biomaterials.  This includes a 
detailed understanding of biodegradability, in particular polymers, and µWDLORULQJµQHZ materials 
where degradability is carefully controlled37, 38. Native ECM has an ability to coordinate stromal 
cells for synthesising new tissue (e.g. if injured) with control over tissue structure though the 
regulation of cell phenotype.  Biomaterials act as an artificial extracellular matrix (ECM) and in 
the context of a scaffold must have biological and mechanical properties that match the native 
body tissue, they must facilitate the localization and delivery of cells and/or transforming factors 
to desired sites in the body. This includes providing a two or three-dimensional space for the 
formation of new tissues with appropriate structure, and guiding the development of new tissues 
with appropriate function. The design and selection of the biomaterial is therefore an important 
factor in the development of engineered tissues, and preferably be capable of controlling the 
structure and function of the engineered tissue in a predesigned manner39. Among these properties, 
the release of degradation products should not provoke inflammation and must be removed from 
the body via metabolic pathways. According to American Standard Testing Materials (ASTM 
D20-96) degradation is defined as, ³plastic designed to undergo a significant change in chemical 
structure under specific environment conditions resulting in a loss of some properties and its 
applications in a certain period´ The degradation rate and the concentration of degradation 
products in the tissues must therefore be of an acceptable level40,41. The more general definition of 
polymer degradation is; ³the chemical degradation of macro-molecules to achieve the perfect 
difference from the materials physical degradation ?42. However, degradation must be used instead 
of biodegradation when the mechanism of chain scission is not known or demonstrated as being 
cell-mediated41. Degradation mechanisms include hydrolytic, enzymatic and biodegradation24. 
However, it is necessary to consider abiotic reactions (e.g. photo degradation, oxidation and 
hydrolysis) that may also alter the degradation of a polymer either before or during the reaction, 
(or not) due to environmental factors43. Sometimes the definition of biodegradation is not 
accurately described44, for example a material can undergo degradation by enzymes in vitro, 
however, this degradation may fail in vivo due to the absence of the required body enzymes. 
Therefore, biodegradation is caused by cell activity. Similarly, in vivo, degradation as a result of 
hydrolysis by water located in tissues and organs is not biodegradation; it should be described as 
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hydrolysis or a hydrolytic degradation. Technically, biodegradation is the breakdown of a material   
due to specific biological activity and the mechanism related to this activity is proved. Related to 
this is where a cell-mediated chemical modification arises in which a main chain scission event is 
strictly speaking bio-alteration (and not biodegradation).  
 
2.2- Biodegradable Polymers 
Polymeric materials have been used in clinical applications for a number of years45,46,47, however 
the clinical and biological requirements vary according to the nature of the application. Numerous 
techniques have been used to modify and fabricate different compositions to achieve exact 
requirements for clinical use48, typically based on control of molecular weight, polydispersity, 
crystallinity, thermal transition and degradation rate. All of these factors can strongly affect the 
polymer scaffold properties49. There are three general types of biodegradable polymers: synthetic, 
natural and hybrid materials, which have been gaining recent attention due to their superior 
characteristics in regenerative therapies. These materials can be produced with high structural 
precision employing assembly strategies to control properties such as stiffness, degradation and 
porosity50. A wide range of natural and synthetically derived polymers are capable of undergoing 
degradation, however synthetic biodegradable polymers have found more versatile and diverse 
biomedical applications, arguably due to a more facile ability to undertake tailorable designs and 
chemical modifications51. 
The most commonly used synthetic polymers for tissue engineering and drug delivery are aliphatic 
polymers, and include poly (lactic acid) (PLA) and poly (glycolic acid) (PGA), poly (lactic-co-
glycolide) (PLGA), poly (ܭ-caprolactone) (PCL), poly (p-dioxanone), plus copolymer soft 
trimethylene carbonate and glycolide. These materials are approved by the U.S. Food and Drug 
Administration (FDA) for human clinical applications52. PLA exists in three forms - D-PLA 
PDLA, L-PLA (PLLA). Blends of D-PLA and L-PLA (PDLLA), PLA, PGA and PLGA 53-55have 
been used clinically to treat patients suffering from damaged or lost organs or tissues and for drug 
delivery systems 56-59. These polymers have been demonstrated as being biocompatible and 
degrading into non-toxic products, with a controllable degradation rate when implanted in vivo. 
Other biodegradable synthetic polymers include poly anhydrides, polyphosphazenes, 
polyurethanes, poly(glycerol sebacate), synthetic hydrogels and functional synthetic polymers, 
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with a range of other tissue engineering applications including restorable sutures60, 61, drug delivery 
systems62, 63, artificial skin 64-66, wound healing62, 67, 68 and orthopaedic implants69.  
These synthetic biodegradable polymer materials can be synthesized by controlling their 
fundamental building block units to give various properties such as uniformity, which are free 
from immunogenicity. High molecular weight aliphatic polyesters are mostly synthesized by 
condensation or ring-opening polymerization. The basic and generic structure of all aliphatic 
polyesters is very similar and the only difference is the pendant groups, where a change contributes 
to differences in molecular weight and crystallinity.  This directly affects the kinetics of 
degradation49. These synthetic polymers contain chemical bonds in their backbone that undergo 
breakdown in the presence of water. Polymers having functional groups of esters, ortho-esters, 
anhydrides, amides, urethane, lactones, and lactams are categorized as polymers that degrade 
through hydrolysis. However, it is important to clarify that in vivo, degradation resulting solely 
from hydrolysis through water present in tissues is not biodegradation, and should be referred to 
as hydrolysis or hydrolytic degradation41. 
In addition, synthetic hydrolytically degradable polymers possess number of advantages compared 
to natural polymers when used in biomedical applications, including tailored-made porosity, 
degradation time and mechanical characteristics68. They are often cheaper than biological scaffolds 
and can be produced in large quantities under controlled conditions, and have a long shelf life70.  
Synthetic polymers are generally preferred for medical applications, due to manufacturing 
reproducibility compared to natural polymers, which in contrast have little control over chemical 
structure. Furthermore, synthetic polymers do not tend to display problems when used as 
biomedical implants due to this minimal batch-to-batch variation, and are therefore more 
reproducible37. The degradation of synthetic polymers is very much dependent upon the chemical 
structure of their functional groups. Different polymers show a variable degree of degradation, as 
some are more water stable than others. Chemical structure therefore plays an important role in 
materials selection and design for tissue engineering scaffolds. Figure 1 shows the order of 
hydrolytic degradation of various chemical structures. Based on these observations one can design 
and select a specific polymer for a required biomedical application. Chemical reactivity depends 
upon the level of electrophilicity of e.g. a carbonyl moiety (C=O) and stability of the leaving group.  
(Insert Figure 01) 
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Natural biopolymers include polysaccharides(e.g. starch, alginate, chitin/chitosan, hylauronic acid 
derivatives) or proteins (e.g. soy, collagen, fibrin gels, silk)71. They serve as intrinsic templates for 
cell attachment and growth because of their inherent biocompatibility. However, they also have an 
ability to stimulate an immune response. The molecular structure of natural polymers is highly 
organized containing extra cellular ligands that can bind to cell receptors. Although naturally 
derived polymers are biocompatible, there are some disadvantages including not being available 
in bulk quantities, being expensive, and difficulty in processing into a desired shape when used as 
a scaffold for tissue engineering. The degradation rate of both natural and synthetic polymers can 
vary from patient to patient, because the degradation of natural polymer materials is dependent 
upon enzyme activity, which is a variable within patients. 
Generally, the majority of naturally occurring polymers are degraded under enzymatic 
conditions37. For example, chitin as enzymes are well known for the degradation of chitin 
(chitinases originating from fungi, bacteria, and plants etc.72, 73.) Degradative chitinases are divided 
into two groups; endo- and exo-chitinases. Figure 2(A) shows the pattern of chitin degradation by 
various catalysts including endo- and exo-chitinases (interestingly, lysozyme is also known to 
break the E-1,4-linkage in the natural carbohydrate polymers74, 75). Chitosanase leads the E-1,4-
linkage in the D-glucosamino moieties in the chitosan as shown in Figure 2(B). Hyaluronic acid 
undergoes catalytic degradation in the presence of mammalian hyaluronidase, assisting in the 
hydrolysis of 1,4-bonds between the D-glucuronic acid and N-acetyl-D-glucosamine, as shown in 
Figure 2(C). 
Another very common naturally derived polymer is collagen, of which 28 different types have 
been described. Collagen is found in mammalian connective tissues; consisting of up to 30% of 
all proteins that are present in the human body that provides strength and flexibility to tissues. The 
most common, representing about 90%, is type I collagen. Collagen I is abundantly found in 
tissues, with higher levels found in tendon, skin, bone and fascia. It has been extensively 
researched for developing biomaterials in tissue engineering76. Because of its distinctive physical 
strength, porosity and biological properties i.e., phylogenetical studies showed a primary sequence 
and helical structure as well as mild immune-reactive recital77-79. Collagens undergo degradation 
in the presence of collagenases and metalloproteases. Collagenases belong to the family of 
endopeptidases, and metalloproteases are proteases that require a metallic catalyst for their 
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activity. These enzymes attack the collagen in the triple helix region, which is composed of 
polypeptide strands bearing tri-amino acid blocks of glycine-proline-hydroxyproline, and 
responsible for the repeating helical structure80 [Figure 2(D)]. 
(Insert Figure 02) 
 
Hybrid or composite materials behave in such a way that better properties are achieved for scaffold 
function and have been commonly used for clinical applications81-83. Polymeric material blends 
have been fabricated by the combination of synthetic and natural, natural plus natural and synthetic 
plus synthetic polymers, to improve the mechanical properties, to improve processability, to lower 
production costs, or to improve cell compatibility84. Bioactive phases increase hydrophilicity and 
water absorption of the polymer matrix, which can change the degradation behaviour of the 
polymers by allowing rapid exchange of protons in water from ceramics85. Biodegradable hybrid 
materials may provide a number of benefits, e.g., an enhanced environment for cell seeding, 
survival, growth, and differentiation due to the osteoconductive function imparted by bioceramics 
(which increases mechanical properties essential for load bearing applications86). The 
composition, structural and functional versatility of hybrid materials accounts for a range of 
tuneable physicochemical properties, which are highly suitable for designing organ specific tissue 
engineering constructs. 
 
3. Organ Specific Regeneration using Biodegradable Materials 
3.1 Skin            
Skin is the most exposed and largest body organ with an approximate surface area of 1.5-2.0 m2 in 
the adult human body and 12-15% by weight.  It is a multifaceted organ that is frequently subject 
to burn and wound injuries. Skin anatomy reveals a three-layered structure: the stratified 
epithelium or epidermis, separated from an underlying tissue stroma or dermis and a well-
characterized cellar layer of subcutaneous tissue or hypodermis 87. The functions of skin are to 
maintain the integumentary system (that includes but is not limited to) protection against any 
external physical, chemical and biological insults88, preventing excess water loss from the body 
and thermoregulation. Skin damage can have a number of causes e.g., traumatic injury, burns, 
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surgery, non-healing ulcers and chemical injury. These can cause extensive skin loss and require 
instant treatment to restore structure and function. For several decades, scientists and clinicians 
have been designing and fabricating new tissue engineering scaffolds to develop artificial skin or 
wound healing strategies89.  
A noticeable breakthrough is in the development of artificial skin, which is being used in burn 
patients90-93. The plus point of such a development is that artificially grown skin can be stored in 
tissue banks and be used when required. The major drawback with existing burns treatments using 
skin grafting is that patients need to wait for a number of weeks while the skin is grown 
autonomously. The donor site for this is also a new wound and thus a potential site for infection 
or scarring. In addition, the donor site is limited and so a major limitation in patients with extensive 
burns. Figure 3 illustrates an example of a patient treated using tissue engineered skin. 
(Insert Figure 03) 
 
In 1997, the first tissue engineered skin product TransCyte (Shirepid, California, USA) was 
launched. This was a non viable productthat was comprised of silicone, a nylon membrane and 
collagen containing neonatal fibroblasts grown for 17 days to produce a matrix. It was followed 
by Apligraf® (Organogenesis, Canton,USA) in 1998. Apligraft was used in the chronic 
woundshealing when such wounds were previously failed in healing by using other methods of 
treatment. Fifty-six percent of patients treated using Apligraft had full wound healing in 
comparison with 37% of patients who were treated using standard wound care protocols. Figure 4 
shows the appearance of a wound before and after application of Apligraft94. 
 
(Insert Figure 04) 
 
 Dermagraft® (Advanced BioHealing, Westport, Conn) is a synthetic product which either uses 
polygalactic or polyglycolic acid meshes combined with neonatal fibroblast to enhance wound 
healing as temporary skin substitutes. It was followed by the development of OrCel® (Ortec 
International US Inc., New York, USA) in 2001. 
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According to a research report compiled by ECRI Institute/Evidence-based Practice Centre (EPC) 
under contract to the Agency for Healthcare Research and Quality (AHRQ, USA)95 its use is only 
for chronic wounds such as diabetic foot ulcers, pressure ulcers, and vascular ulcers (including 
venous ulcers and arterial ulcers)96. A wealth of literature reviews elsewhere97-98 document a range 
of skin substitutes and techniques investigated for in vitro testing and employed as model skin88, 
95, 97-104
. 
Extra Cellular Matrix (ECM) plays a vital role in tissue engineering. It supports the growth of 
proliferating cells (in particular, fibroblasts) and serves as a scaffold post injury, and hence is a 
major component in the process of tissue regeneration. Fibroblasts produce ECM constituents and 
through it communicate with each other. The ECM can signal to the fibroblasts and control cell 
phenotype, genetic expression, development, protein expression and the function of these cells. 
Such interactions are influenced by the microenvironment, which provides a niche for homeostatic 
modulation of ECM. When considering skin substitutes, development of biomedical materials 
should ideally aim at mimicking the ECM by incorporating appropriate factors, or pharmacological 
agents, at physiological quantities and durations97. Numerous biomaterials are employed as skin 
implants, ranging from naturally occurring collagen gels/sponges, alginates, polypeptides, glycol 
saminoglycans, hyaluronan and fibronectin to synthetic materials e.g., polyvinyl chloride, poly 
lacetate/glycolate fabrics (PLGA) etc. 88, 97, 105.Researchers are constantly trying to find an ideal 
skin graft106. Huss et al107 reported on the development of biodegradable polyurethane-urea 
(PUUR) scaffold for dermis regeneration. After in vitro and in vivo assessments, the fibrous and 
porous forms of PUUR scaffold showed biocompatibility with human dermal fibroblasts. Thus, 
the cells could attach, proliferate and migrate around the biodegradable scaffolds. Porous scaffold 
discs of dimensions 4 mm diameter, 2 mm-thick) with a polymer solution (of 12% w/w or 9% 
w/w) were inserted intra-dermally into four volunteer healthy patients. Increased growth of 
fibroblasts was observed on all materials and after eight weeks, the scaffolds were fully occupied 
with fibroblasts. Production of procollagen was observed that signified the existence of functional 
and active cells. The fibroblasts stained immune histochemically for procollagen and von 
Willebrand factor, demonstrating neocollagenesis and angiogenesis contained within the scaffolds.  
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These biodegradable materials have shown potential applications in dermal regeneration 91, 107, 108. 
Among various biodegradable polymers for skin regeneration, polyurethanes have attracted 
interest due to their tuneable mechanical properties, biocompatibility and structural adaptability 
109
. In a number of other studies 110-112, polyurethane-based dressings are reported which are 
considered as superior to hydrogels. Furthermore, successful culturing of keratinocytes has also 
been reported on polyurethane membranes 113. Nonetheless, biodegradable polyurethanes as 
dermal scaffolds have not been fully explored. Greenwood et al. 109 reported on a study of a dermal 
skin substitute for restoration of major skin loss caused by burn injury. The authors carried out in 
vitro studies on three derivatives of 1RYR6RUE Polynovo Ltd. Australia), a class of 
biodegradable polyurethane used as a dermal scaffold. Results showed biocompatibility, nominal 
cytotoxicity on skin cells and facilitation of cell development i.e., growth of human keratinocytes, 
dermal fibroblasts and microvascular endothelial cells in co-culture. Furthermore, one of the skin 
substitutes (BTM-2, Biodegradable Temporising Matrix, PolyNovo Ltd. Australia) exhibited a 
desired degradation profile for a dermal scaffold and was developed into a 3-dimensional porous 
matrix for further studies. In-vivo studies 114 were carried out in both rats and sheep, with 
sXEFXWDQHRXVLPSODQWDWLRQRIWKUHH1RYR6RUEderivatives which revealed no toxic effects. The 
authors demonstrated an inflammatory response and granulomatous reactions that were 
comparable to clinically used materials, e.g. VXWXUHV DQG ,QWHJUD (Integra Life Sciences 
Corporation, NJ, USA) dermal substitutes.  
These dermal scaffolds, both the non-optimised skin substitutes DQG ,QWHJUD restrict wound 
contraction and allow re-epithelialisation over the dermal granulation tissue with the growth of 
normal basement membrane. Both in vitro and in vivo studies show that a basic bi-layered 
composite skin was created, which may eliminate a dependence on skin auto grafts via non-
optimized BTM-2 matrix. The authors suggest further the generation of vascular structures by 
culturing MVECs in the BTM-2 matrix, with the potential for developing a µSUH-YDVFXODUL]HG¶
composite skin substitute (and is of relevance to other tissue engineered organs 109, 114. 
Wang et al115 reported an interesting study for skin restoration and wound healing. They introduced 
a novel collagen/hyaluronic acid (HA)/gelatine based sponge-like scaffold for human skin 
regeneration. The scaffold offered an optimal pore size with an average pore diameter of 
132.5±8.4µm observed under SEM. The swelling ratio was examined by water absorption and 
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showed a value of over 20g water/g of dried scaffold. Enzymatic degradation was demonstrated 
by lysozyme, hyaluronidase and collagenase I assays in a time- and dose-dependent fashion and 
observed by measuring a reduction in weight. The scaffold degraded gradually to 38.1±2.6% and 
36.4±5.1% of original weight after one week using 10,000 and 30,000 U/mL of lysozyme 
respectively. Similarly, when using 30 U/mL of hyaluronidase, the scaffold maintained about 10% 
weight after a 5-day examination. With 50 U/mL of hyaluronidase, the scaffold was degraded after 
7 days. Furthermore, in 20 U/mL collagenase I, the scaffold degraded almost completely in 
approximately 3 hours. In contrast, 10 U/mL reported 45% of remaining scaffold in comparison 
to its starting weight. It was further investigated that with human skin cells growing for 7 days, 
SEM studies indicated surface degradation of the scaffolds. This was attributed to enzymatic 
digestion, signifying the biodegradable properties of the scaffolds. Human epidermal 
keratinocytes, melanocytes and dermal fibroblasts were cultured on the porous scaffold and 
immunofluorescence microscopy confirmed a normal human skin layer distribution i.e., the 
scaffold was able to mimic the human epidermis and dermis structures.  Furthermore, the authors 
reported that the amount of collagen was quantified to 50% higher after skin cell seeding, as 
compared to cells seeded on culture wells. The in vivo histological outcomes showed that the 
scaffold wound healing was faster, with no further inflammation or side effects115.  
Recently, Lagus et al116 in a clinical/histological study compared three different strategies to heal 
excised burn wounds by using Integra® (Integra LifeSciences Corporation, USA), Split Thickness 
Skin Graft (STSG) from a donor , and a viscose cellulose sponge CellonexTM  (Vivoxid Ltd, 
Finland), respectively. Integra®, is a biodegradable porous skin substitute consisting of bovine type 
I collagen and chondroitin-6-sulphDWHIURPVKDUN¶VFDUWLODJHZLWKDWHPSRUDU\HSLGHUPal substitute 
layer made of 0.1mm synthetic polysiloxane matrix. The silicone layer regulates the moisture 
content from the wound to a permeability value of 0.5 mL/cm3, reported for the epidermis of 
human skin117. This layer also provides a protective barrier to the host body undergoing a thin split 
thickness skin graft substitution from infectious microorganisms. It facilitates the formation of a 
neodermis, autologous extracellular matrix (ECM) and wound bed for a thin STSG. In contrast, 
CellonexTM viscose sponge, can be obtained from cellulose. It has shown granular tissue growth 
on wound beds and is known for its optimal pore-size, open cell-to-cell structures, homogeneity 
and purity. The sponge contains a viscose cellulose matrix as a main component, which is 
supported by cotton fibres118. The flexible architecture allows the free passage of cells into the 
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inner parts of the sponge119. However, in vivo cellulose sponge degradation is believed to be result 
of chemical, biological, and mechanical interactions120. These materials were tested and compared 
in ten adult patients116 and results showed that STSGs performed well in muscle fascia, on 
vascularized Integra® and on wound surfaces possessing a cellulose sponge. Minimal 
inflammation was observed in CellonexTM treated areas, in contrast to other materials. Most 
neutrophils, histiocytes, and lymphocytes were observed with significant differences on days 7 
and 14. Entire vascularization of Integra® occurred later, as compared to the other materials (STSG 
showed most myofibroblasts on day 14). However, it was noted that fibroblasts and myofibroblast 
number may show a slow increase in Integra®, in contrast to wound beds treated with other 
materials. Furthermore, it was also revealed that both the maturation of scar tissue and the fibres 
of Integra® may persist for a year or longer, respectively. From the results, it was concluded that 
Integra® is a better skin substitute as compared to other materials, but that from the 12 month 
investigations of histological and immune histochemical outcomes, proposed that three strategies 
could be clinically adopted116. 
Hypopigmentation is the common problem while using tissue engineered skin grafts to treat burn 
wounds121. A study has been published to investigate the difference between the normal and 
vitiligo melanocytes in artificial skin grafts. It was observed that skin fibroblasts regulate the 
pigmentation in tissue engineered skin grafts. Figure 5 shows melanocytes in the epidermis in 
tissue engineered skin. Melanocyte function depends upon fibroblast presence. In the absence of 
melanocytes the authors observed no pigmentation. In the presence of fibroblasts and melanocytes 
(isolated from pale skinned patients) unpigmented skin was observed [Figure 5(A)], whereas in 
the absence of fibroblasts under same conditions pigmentation arose [Figure 5(B)]122. 
 
(Insert Figure 05) 
 
Biobrane® (Bertek Pharmaceuticals Inc., USA) due to its lower cost, ease of storage, application 
and fix, and reliable when used according to guidelines and being efficacious in treating partial 
thickness burns are the main reasons of its popularity in usage. By comparison of Biobrane® and 
cadaveric allograft for temporizing the acute burn wound, Austin et al. founded that Biobrane® is 
superior in terms of lower procedural time and associated cost because of mainly the relative ease 
of its application. Currently Biobrane® is used as an alternative to cadaver allografts as temporizing 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
15 
 
dressings after excision of major burn injuries. However, the limitation of this technique is that 
wound bed must be meticulously prepared to prevent any infection and there is still a lack of 
existing literature and published clinical protocols proving that it could be a suitable replacement 
of the human skin allografts, especially in the treatment of full thickness burn wounds. Despite 
that, Biobrane® is still widely used as a synthetic skin substitute as well known for its success in 
the definitive management of partial thickness burns in many centres (Fig. 6)108 
 
 
 
 (Insert Figure 06) 
 
Advanced wound healing for diabetic foot ulcers (DFUs) has now started to focus on stem cell 
therapy for improved healing. Much of the research is still in the starting phases with a paucity of 
robust clinical trials, but it could prove to be an important method for advance wound healing in 
difficult patient populations123, 124. 
Adipose stem cells (ASCs) being a type of adult stem cells have been proven to be a useful cell 
resource for tissue regeneration. Cell therapy plays a major role in regenerative medicine of this 
century where ASCs holds a key position. These cells have many clinical applications, including 
fat grafting, overcoming wound healing difficulties, recovery from local tissue ischemia and scar 
remodeling. Diabetic ulcers and chronic radiation ulcers are notorious for their recurrence. These 
lesions do not improve over time and tend to become worse. Recently, cell therapy using ASCs 
has been shown to be a good potential alternative technique because it is less invasive than re-
constructive surgery and the cells can be directly placed onto target areas in cutaneous lesions. 
Sufficient numbers of ASCs can easily be harvested by liposuction and fat tissue digestion. The 
addition of cells to the defect may reinforce local regeneration capabilities that have been 
exhausted during the course of prolonged disease processes. The ease of repeating the procedure 
during the course of regeneration is the main advantage of this type of tissue engineering. This 
type of cell-based therapy may be a good treatment option for small traumatic defects or skin 
cancers to avoid more substantial reconstructive surgeries using local flaps125. In order to obtain 
recovery from ischemia, using ASCs is very effective until 4-5 days after the onset of 
complications and can reduce the area of necrosis in 7 days after the onset as shown in Fig 7126.  
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(Insert Figure 07) 
 
3.2 Nerves           
Compared to other types of trauma, nerve injuries are particularly complicated as mature neurons 
do not replicate. However, under the right conditions axon extensions of peripheral nerve injuries 
can regenerate, if reconnection with the distal stump arises eventually restoring function. Injuries 
to the central nervous system differ significantly from peripheral nerve injuries, in regards to 
outcomes following traumatic injury (in that permanent paralysis of organs distal to the injury site 
is usual). Major differences for this include the inability of spinal neurons to re-grow, 
predominantly due to biochemical inhibitory molecules secreted at the injury site and the formation 
of a glial scar. Current treatments for injuries to peripheral nerve defects typically rely on donor 
tissue obtained following second surgery, typically autologous nerve, vein, or arterial graft sutured 
to the two ends of the severed nerve127. However, this method has raised the issue of functional 
loss at the donor site, formation of potential painful neuromas, structural differences between 
donor and recipient grafts, and shortage of graft material for extensive repair128. Artificial nerve 
guidance conduits have been in development for many years, which bridge the gap between the 
nerve stumps and aid nerve regeneration. The guide may be implanted empty, or it may be filled 
with growth factors, cells, or fibres. Micro-braiding is a novel technique for the fabrication of 
polymeric nerve guide conduits composed of biodegradable PLGA fibres. The micro-braided 
nerve guide conduit with a fibre architecture has shown promotion of axonal regeneration, with no 
inflammatory response or swelling. It degraded from the implantation site after serving its purpose. 
An in vivo study was conducted on the sciatic nerve in rats and showed a 90% success rate129. The 
results showed that the fibrous tubular structure did not collapse and had the necessary strength to 
withstand adjacent muscular forces surrounding the conduit. The micro-braided conduit had the 
required permeability to allow for the passage of nutrients from the external environment into the 
conduit lumen to promote nerve regeneration. In a separate study130, the fabrication of a fibrous, 
porous, flexible and biodegradable tubular scaffold using PLGA and chitosan was proposed. Here, 
a PLGA conduit exhibited negligible or minimal swelling and thus maintained dimensional 
integrity. However, the chitosan conduit showed a 60% swelling, which had to be taken into 
consideration before designing the scaffold for practical applications. Both PLGA and chitosan 
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scaffolds showed good biocompatibility. Cell morphology was not altered but remained similar in 
both polymers.  
An emerging area of nerve guide manufacture using synthetic materials includes the use of additive 
layer manufacturing.  The very first 3D printed nerve guide was produced from poly (ethylene 
glycol; PEG) by UV light induced photo curing using stereo lithography. This enable a very precise 
shape and structure of guide to be manufactured via computer aided design and therefore has a 
number of advantages over tradition manufacturing methods such as moulding and extrusion. A 
small common fibular nerve injury model (3mm) was studied in a mouse, which showed equivalent 
axon number and distance regeneration after 3 weeks compared to a nerve graft. Notwithstanding, 
the development of more suitable materials for nerve repair beyond PEG is currently ongoing.   
The idea that biomaterials might have electrically conductive properties for nerve repair has been 
explored largely without success. However, composite materials from the blending of conductive 
(CPs) and biocompatible polymers are fast emerging as successful biomaterials for the 
regeneration of the myocardium due to their unique conductive and biological recognition 
properties and can assure a more efficient electroactive stimulation of cells. Recently, research has 
been focused on the synthesis of conductive polymers to fulfil basic biocompatibility and 
biodegradability properties by combining conducting and degradable units131. A series of 
electroactive and biodegradable polymeric materials were prepared by blending PLLA and poly 
(glycol tetra-aniline) (PGTA). The blended polymers showed good solubility and thermal stability, 
the cytotoxicity and biocompatibility of the materials were evaluated with positive results 
obtained. Cell culture results showed that PLLA/PGTA blended materials could accelerate the 
differentiation of rat C6 glioma cells compared with pure PLLA. They recommended that the 80/20 
wt.% PLLA/PGTA blend material showed the best effect and these biodegradable PLLA/PGTA 
polymer blends are shown to be electroactive132. A novel electrically conductive biodegradable 
poly phosphazene polymer containing aniline pentamer (AP) and glycine ethyl ester (GEE) as side 
chains was obtained by a nucleophilic substitution reaction. The electrical conductivity of the 
polymer was ~2 × 10í5 S/cm (i.e. in the semiconducting region) upon protonic-doped experiments. 
Furthermore, the polymer proved to promote cell adhesion and proliferation in vitro using 
Schwann cells. These polymers also showed good solubility in common organic solvents and good 
film-forming properties, and consequently potential applications as scaffolds for neuronal and 
cardiovascular tissue engineering applications133. 
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In another study, hyper-branched degradable conducting copolymers were blended with poly 
caprolactone to construct electroactive tubular porous nerve conduits by a solution-
casting/particle-leaching method. Thermal and mechanical properties, hydrophilicity, 
morphology, toxicity and conductivity (values between 3.4 × 10í6 and 3.1 × 10í7 S/cm were found, 
depending on the composition) and were determined for blends doped with or without 10 camphor 
sulfonic acid. The results obtained supported their potential for neural tissue engineering 
applications134. McKeon and group studied several polyaniline and poly(D,L-lactide) 
(PANi/PDLA) mixtures at different weight percentages and were successfully electrospun from 
1,1,1,3,3,3-hexafluoroisopropanol solutions and their conductivity and biocompatibility evaluated. 
It was claimed that the successful results were only attained when the PANi content reached 25%. 
Specifically, this scaffold could conduct a current of 5mA and had an electrical conductivity of 
0.0437 S/cm. Primary rat muscle cells were able to attach and proliferate over all the new scaffolds, 
which degraded during the process. The polymer degradation and shrinkage may prevent the blend 
from being used as the primary component of a biomedical device, but its usefulness as a 
biocompatible coating on devices such as sensors was proposed135. Biodegradable semiconducting 
melanin films have also been studies for nerve regeneration.  Melanins are naturally occurring 
pigments and exhibit unique electrical/biological properties and were used as melanin thin films 
to enhanced Schwann cell growth and neurite extension, compared to collagen films in vitro. 
Furthermore, melanin implants were significantly resorbed after 8 weeks136. 
Among natural polymers, collagen137, 138, chitosan139 and alginate140 have been used for 
constructing nerve guidance channels. Addition of collagen gels to the lumina of nerve conduits 
speeds the rate of nerve regeneration. A number of collagen based nerve tubes have shown to 
support regeneration of nerve defects in vivo. However, repair was limited to gaps less than 30mm 
long141. Alginate was employed in tubular and non-tubular repair of a long peripheral nerve defect 
injury. In vivo studies showed the recovery of 50mm gap of the sciatic nerve of cats, treated by 
tubular repair or non-tubular repair. In the tabulation group, a nerve conduit consisting of 
polyglycolic acid mesh tube filled with an alginate sponge was implanted into the gap and the tube 
was sutured to both nerve stumps. In the non-tabulation group, the nerve defect was repaired by a 
simple interpolation of two pieces of alginate sponge without any suture. The animals in both 
groups exhibited similar recovery of locomotor function. After three months, axonal elongation 
and re-innervation in both the afferent and efferent systems were detected by electrophysiological 
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examination. Intracellular electrical activity was also recorded, which is directly indicative of 
continuity of the regenerated nerve and restoration of the spinal reflex circuit. Eight months after 
surgery, many regenerated myelinated axons with fascicular organization of peri neural 
(fibroblast) cells were observed within the gap, peroneal and tibial branches were found in both 
groups, while no alginate residue was found within the regenerated nerves. Morphometric analysis 
of the axon density and diameter revealed no significant differences between the two groups142. 
 
3.3 Blood Vessels      
There is a substantial patient demand for vascular bypass grafts due to atherosclerosis and related 
cardiovascular diseases. Vascular disorders are the leading cause of mortality in Western countries. 
Several studies have been focused on the development of biodegradable vascular grafts able to 
temporarily substitute the blood vessel and allow for complete regeneration over a predetermined 
time period. Several biodegradable synthetic polymers143, and natural polymeric materials like 
collagen144 have also been evaluated for developing a successful vascular graft. However, due to 
the lack of suitable mechanical properties, unsuitable rates of degradation and the poor capacity to 
create an optimal microenvironment for cell adhesion and differentiation, none of these materials 
has displayed the required properties for further application in the human body.  
However, different methods exist to prepare polymeric vascular grafts, which should allow greater 
control on both the mechanical properties and the micro- and nanostructures of the product. An 
ideal artificial graft should be mechanically compatible with the natural arteries and surrounding 
tissue and should also mimic the extracellular matrix morphology; it should have a nano scale 
topography (5 to 500nm) with high porosity and adequate pore sizes (5±500µm) to enhance cell 
attachment and proliferation for the regeneration of the natural tissues. The first tissue-engineered 
blood vessel substitute was created by Weinberg and Bell in 1986145. They generated cultures of 
bovine endothelial cells; smooth muscle cells (SMCs) and fibroblasts in layers of collagen gel 
supported by a Dacron mesh. Although physiological pressures were sustained for only 3±6 weeks, 
they did demonstrate the feasibility of a tissue-engineered graft with human cells. Since then, 
strategies to create a suitable material for a vascular graft have focused on three areas of research: 
1) coatings and surface chemical modifications of synthetic materials; 2) biodegradable scaffolds 
and 3) biopolymers. Niklason and colleagues have developed a pulsatile bioreactor to remodel 
PGA scaffolds seeded with bovine smooth muscle and endothelial cells146. After a 10-week culture 
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period, the resulting tissue-engineered vessel displayed a burst pressure of up to 2300mmHg. After 
5 weeks, the PGA scaffold had degraded to 15% of its initial mass147. Shin'oka et al reported the 
use of PCL-based scaffolds to engineer venous blood vessels. The PCL/PLA copolymer was 
reinforced with woven PGA and seeded with autologous smooth muscle and endothelial cells 
harvested from a peripheral vein. After 10 days, the construct was implanted as a pulmonary 
bypass graft into a 4-year-old child148. An alternative strategy to synthetic and degradable scaffold-
based vascular grafts is the manipulation of proteins that constitute the architecture of native ECM. 
Weinberg and Bell first reported the use of collagen gels as substrates for cells in vascular tissue 
engineering. Since then, Habermehl and colleagues have developed a process to obtain large 
quantities of collagen from rat tail tendons to allow the scale-up of production149. The 
shortcomings of a relatively stiff collagen-based scaffold have motivated researchers to explore 
the potential of more elastic fibrin gels in vascular tissue engineering150. One such example is the 
fibrin-based vascular graft developed by Swartz and colleagues, who incorporated bovine SMCs 
and endothelial cells into the gel151. The grafts were implanted in the jugular veins of lambs and 
remained patent for 15 weeks. Upon histological examination, the constructs were found to contain 
both collagen and elastin, with the mechanical integrity comparable to that of native coronary 
arteries. Recent developments in the field of nanotechnology have facilitated vascular tissue-
engineering efforts in mimicking the nanostructure of native vasculature, thereby directing 
mechanical and biologic performance of the bulk material. One such application is electro spinning 
of synthetic polymers and naturally occurring materials into nanofibres152,153, 154. In these studies, 
use of electro spinning to create nano-fibrous scaffolds composed of collagen-blended degradable 
PLLA-co-PCL was demonstrated. Results indicated that the blended nano-fibres supported 
endothelial cell attachment and spreading, and preserved the endothelial cell phenotype155. 
Poly amino acid-graft-polyester copolymers have been functionalized with heparin, for a potential 
use in tubular structures for vascular regenerative medicine156. The fabricated scaffold had 
morphological characteristics like those of natural extracellular matrix, a suitable rate of 
degradation in simulated physiological medium (after 60 days approximately 50% of the scaffold 
degraded), the ability to be easily functionalize and allow endothelial cell adhesion and 
proliferation. Bio functional vascular grafts were synthesized by electrospinning PCL solutions157. 
The obtained fibres showed tensile stresses above 2MPa and up to 7.4MPa and tensile strain at 
failure values in the range of 200±1200% after ࢢ-sterilization. These values are above those for 
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natural human blood vessels (1.4MPa and 100%). These PCL-based vascular grafts were 
implanted into UDW¶VDUWHULDOFLUFXODWLRQDVDQDEGRPLQDODRUWLFVXEVWLWXWH$OOLPSODQWHGJUDIWVZHUH
fully potent up to 12 weeks after implantation, and none of the vascular grafts at the three different 
time points (3, 6 and 12 weeks) demonstrated thrombosis or aneurismal dilatation. Histological 
analyses revealed a homogeneous cellular infiltration associated with polymer degradation and 
extracellular matrix deposition, and a complete endolisation with little intimal hyperplasia. 
  
3.4- Heart 
Cardiovascular related deaths surpass cancer in general as the leading cause of death worldwide158. 
The reSRUW³*OREDO$WODVRQ&DUGLRYDVFXODU'LVHDVH3UHYHQWLRQDQG&RQWURO´E\WKH:+2KDV
identified cardiac related deaths will continue to increase in future159. Increased interdisciplinary 
research is therefore exploring multidimensional therapeutic aspects of cardiovascular diseases 
and new materials are continuously being explored. However, current therapies dealing with 
multifaceted cardiovascular damage lack the potential of intrinsic cardiac tissue regeneration 160. 
To date, the exact relationship between the components of engineered biomaterials, the immune 
system and tissue regeneration has yet to be fully understood. The ultimate goal of tissue 
engineering is to develop therapeutic strategies that will stabilize, amend and improve 
cardiovascular anatomy and physiology161. Nowadays, cardiac tissue engineering and regenerative 
medicine (TERM) has become the focal point for the repair of damaged heart tissue162. TERM 
related approaches have shown to minimize the need for ventricular remodelling. Different 
strategies have been adapted to design and fabricate polymeric scaffolds for heart tissue 
engineering163. One potential application of polymeric scaffolds is the development of efficient 
degradable heart patches. These heart patches can provide an optimal platform for cellular growth 
over a period of time164. A recent review focuses on the engineering of functional three-
dimensional cardiac patches composed of various composite biomaterial including biodegradable 
materials 165. 
A three dimensional fibrin gel construct was reported by Ye et al166, where different concentrations 
of apportioning (a protease inhibitor) promoted controlled degradation of the autologous scaffold 
seeded with fibroblasts.  Microscopic studies of the developed tissue showed homogenous cell 
growth with no signs of toxic degradation or inflammatory reaction. However, the feasibility of 
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forming a cardiovascular graft on the arterial side by the 1mm thick developed tissue appears 
unlikely. A promising approach in cardiovascular tissue engineering was reported in which fibrin 
gel was prepared by a non-woven poly glycolic acid (PGA) fibre mesh coated with  
Polycaprolactone (PCL)167. Human saphenous vein cells were seeded onto the fibrin gel and a 
more mature extracellular matrix was produced in a short time span (days) with a decrease in the 
loss of soluble collagen. Flanagan et al have reported an interesting study where fibrin-based heart 
valves have been developed in a custom-designed bioreactor. The dynamic conditions were 
optimized to accelerate the maturation of engineered valves168. The experimental findings 
demonstrated the potential repair and regenerative role of an injectable fibrin glue after a 
myocardial infarction. This injectable fibrin glue could preserve infarct wall thinning and cardiac 
function after myocardial infarction in MI-induced rat models. The decisive regenerative features 
include; increased cell transplant survival, decreased infarct size and an increased blood flow to 
the ischemic myocardium169,170.  
Another study investigated the use of chitosan to increase the compression modulus of collagen 
based injectable hydrogel matrices. It has been reported that endothelial cells formed significantly 
more vascular-like structures on the collagen±chitosan matrix-hydrogels improved the ventricular 
wall stability and showed an ability to reduce heart dilatation upon myocardial infarction (MI)171. 
Silk protein fibroin of the Indian tropical tasar silkworm A. mylitta (AM) has been used by Patra 
et al to develop 3D scaffolds for the in vitro engineering of a cardiac patch. The resulting 
contractile patches were stable and demonstrated spontaneous beating for 20 days172. Biosynthetic 
hydrogels of poly vinyl alcohol± alginate have also been prepared by Thankam et al., these 
consisted of a semi- and full-interpenetrating polymeric network (IPN hydrogel, PAHG) 
harbouring it suitable for cardiac tissue engineering applications. Its amphiphilic nature and 
moderate water content favoured cellular migration, growth and long term viability of L929 
fibroblasts and H9C2 cardio myoblasts173. Another methodology based on the blending of natural 
polymers i.e. alginate and gelatine, were prepared in the form of films to be used as scaffold for 
myocardial tissue engineering. Cell culture tests with C2C12 myoblasts, degradation in simulating 
body fluids, showed best response for alginate/gelatine 20:80 blends174. Gelatine and fibrin based 
tissue engineered heart valve were designed and operated in a bioreactor with enhanced cell 
attachment and alignment by Kim et al.175. 
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In 2007, Balguid et al. explored the role of collagen content and its cross-links in biomechanical 
behaviour of human aortic heart valve leaflets and in tissue-engineered constructs. Collagen cross-
linked concentration showed a positive linear correlation with the modulus of elasticity, which can 
enhance biomechanical function176. It has been reported that collagen-glycosaminoglycan gels 
matrices were used for mitral valve tissue engineering. Moreover, addition of chondroitin sulphate 
(CS) resulted in a more porous model, which enhanced the bioactivity of seeded valve cells and 
facilitating tissue remodelling177. Gelatine/PCL hybrid fibrous scaffolds were synthesized by 
electro spinning to obtain optimal fibre diameter, pore size and strength, promoting cell seeding 
and finally development of constructs for cardiovascular tissue regeneration178. 
In another study, Landa et al. investigated the use of  bioresorbable alginate hydrogel to provide 
mechanical and physical support to the damaged cardiac tissue after MI179. Several recent reports 
have shown the use of alginate hydrogels in delivery of sequential growth factor VEGF-A(165) 
and PDGF-BB in a myocardial infarction model180. These hydrogels were also able to controls 
delivery of heat shock protein181 and serve as a carrier for dual delivery of insulin-like growth 
factor-1 (IGF-1) and hepatocyte growth factor (HGF)182. Multi-layered cardiac grafts were 
fabricated in vitro using biodegradable electrospun nano fibrous PCL meshes with a unique 
extracellular matrix±like topography by Ishii and his co-workers183. In another study, PLLA-co-
PCL (PLCL) nano-fibres were encapsulated with vascular endothelial growth factor (VEGF) using 
two types of protective agents (BSA and dextran) through emulsion electrospinning. In vitro 
release study demonstrated that the core±shell PLCL±VEGF±DEX nanofibers had potential as 
sustained-release scaffold for cardiovascular tissue regeneration184. Rat smooth muscle cells 
(SMC) were seeded on biodegradable poly (ܭ-caprolactone-co-lactide) (PCLA) patches and were 
checked for cellular penetration in vitro and in vivo. This work permitted the construction of an 
autologous patch to repair congenital heart defects185. 
(Insert Figure 08) 
To date several studies have focused on elastomeric biodegradable poly (glycerol sebacate) (PGS): 
gelatine nano fibrous scaffolds and poly (glycerol sebacate) PGS/fibrinogen core/shell fibres. 
These biomaterials exhibited well-defined anisotropy, mimicking the left ventricular myocardium 
architecture that can be used as constructs for myocardial regeneration and repair186,187. The 
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structural properties of the scaffolds had significant effect on cytoskeletal organization of the cells 
as shown in Fig 8. Prabhakaran and his research group used a blend of synthetic (PLGA) and 
natural (gelatine) polymer to obtain PLGA/Gel nano-fibres via electro spinning. Culturing of 
cardiomyocyte cells on the scaffolds highlighted their potential as biomimetic cardiac patches188. 
In another study, a research group fabricated nano-fibrous scaffolds of electrospun random and 
aligned PCL/gelatine to mimic structurally the oriented extracellular matrix (ECM), which provide 
anisotropic wetting and mechanical properties compatible for cardiac regeneration189. Composite 
scaffolds of poly (1, 8-octanediol-co-citrate) and PLCL were evaluated for their mechanical and 
biocompatibility properties. Electrospun scaffolds were elastic and hence provided the necessary 
mechanical cues required for cardiac tissue repair190. An  electrospun poly(ethylene glycol) 
dimethacrylate/poly (L-lactide) PEGDMA/PLA scaffold with biomechanical properties nearly 
equal to native valve leaflets has also been reported191. Sant et al synthesized nano fibrous scaffolds 
made up of blends of poly(glycerol sebacate) PGS prepolymer with PCL to address the mechanical 
properties relevant to the human aortic valve leaflet192. For the regeneration of infarcted 
myocardium, PGS short fibres were fabricated by co-axial electro spinning, with poly(glycerol 
sebacate) (PGS) as core material and poly-L-lactic acid (PLLA) as shell material193. A 
mechanically compatible multi-layered scaffold of PCL sandwiched in a gelatine±chitosan 
hydrogel was developed194. This could be used as cardiac patch in tissue engineering applications 
owing to its ability to sustain cardio-myocyte viability. Conductive nanofibrous scaffolds of 
melanin, poly(L-lactide-co-İ-caprolactone) and gelatine can electrically stimulate cardio myocytes 
to enhance cell proliferation and therefore are a potential candidate for cardiac patches as 
demonstrated by Kai et al195. 
Scaffolds fabricated from PEG and modified electrospun PCL(ePCL) can serve as a foundation 
for engineered heart scaffolds196. Composite scaffolds consisting of polyglycolic acid coated with 
a thin layer of poly-4-hydroxybutyrate can be used as tri leaflet heart valve scaffold197,198. Other 
biomaterials and tissue engineering research avenues for enhancing cardiac function focus on 
matrices with appropriate mechanical strength for weak cardiac tissue and intrinsic regeneration 
by incorporation of local drug delivery199, 200. In a study by Elamparithi, a novel collagen type I 
scaffold developed by electro spinning in the absence of copolymers showed higher levels of 
desmin. This scaffold was seeded with primary neonatal rat ventricular cardio-myocytes 
(NRVCM) and exhibited sustained cardiac contractile function over duration of 17 days201. The 
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prospect of limiting myocardial damage and facilitating repair and regeneration was addressed in 
this study202. 
  
3.5- Cornea 
Pathological conditions associated with cornea are reported as the major cause of vision 
impairment. Corneal pathology accounts for 4.9 million blind cases worldwide203. Anatomically, 
the transparent corneal layer serves to focus light as it enters the eye. Blindness related to corneal 
disease include many conditions, e.g. NHUDWRFRQXV )XFK¶V G\VWURSK\ DQG 6WHSKHQ-Johnson 
syndrome204 205. The extracellular matrix (EMC) of the cornea is a highly compact and organized 
architecture consisting primarily of collagen (types I to V). This EMC is currently under 
investigation as a prospect therapeutic research area. As estimated by the World Health 
Organization, corneal diseases are a major cause of vision impairment and blindness, second only 
to cataracts as the leading cause of blindness206. Tissue engineering has been widely explored for 
its role in regenerative medicine. Recently, significant progress in corneal tissue engineering has 
been achieved, where researchers have reported on the development of a corneal construct either 
by employing cellular or acellular based techniques that are biocompatible, with physiological 
functional for long term endurance207. Tissue engineering has focused on developing corneal tissue 
that can potentially mimic the native cornea. Synthesis of a corneal construct, epithelial and 
endothelial layers in parallel with a network of nerves have been explored. Reports have identified 
natural and synthetic polymers as the preferred choice of investigation205. In the last few years, 
intensive research efforts have been focused to determine whether key properties of ECM 
macromolecules can be replicated within tissue-engineered biosynthetic matrices to influence 
cellular properties. Tissue engineering of the cornea could overcome shortages of donor corneas 
for transplantation and improve quality. Hydrogels based corneal implants from concentrated 
recombinant human type I and type III collagen have promoted stable regeneration of corneal 
tissue208. For example, Madden et al reported on one of first successful demonstrations of primary 
human corneal endothelial cells on fibroin coated with collagen. This step allowed the evaluation 
of fibroin as a substratum for the transplantation of tissue-constructs for endothelial keratoplasty 
209
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A simple corneal substitute was developed from carbodiimides and N-hydroxysuccinimide cross-
linked collagen and was found to be suitable for transplantation. This was employed in centres 
having a shortage of corneas available for implants210. An artificial cornea of collagen±chondroitin 
sulphate foam approximately equal to human cornea thickness seeded with human endothelial cells 
proved that these collagen-chondroitin sulphate scaffolds are good substrates for artificial cornea 
construction211. Collagen hydrogel matrices were developed by Li et al from collagen I cross-
linked with a copolymer based on N-isopropyl acryl amide, acrylic acid and acryloxysuccinimide. 
These hydrogels were found to be non-toxic and allowed epithelial cell overgrowth and optical 
clarity superior to the human cornea212. Fibrillar collagen sponges were used as a substrate for 
culturing human kerotocyte, epithelial and endothelial cells. This synergy promoted a wound 
healing in the eye213. Liang et al. reported on the formation of an in situ biodegradable and non-
toxic composite hydrogel for corneal endothelium reconstruction214. The hydrogel was made by 
self-cross-linking of water-soluble chitosan and oxidized sodium alginate.  
Biodegradable chitosan±PEG hydrogel films (CPHFs) and chitosan; PCL blends with excellent 
biocompatibility are enviable candidates as substrates for the regeneration and transplantation of 
CECs (corneal endothelial cell)215,216. The transplantation of fibroblast precursors on gelatine 
hydrogel into the corneal stroma may be a possible treatment for corneal stromal regeneration217. 
Some recent studies revealed fabrication of cross-linked porous gelatine scaffolds for in vitro 
cultivation of corneal endothelial cells (CECs)218. These were modified with chondroitin sulphate, 
which enhanced proliferative and biosynthetic capacity of cultured cells219. Cross-linked porous 
gelatine hydrogel discs were inspected for their potential as cell sheet carriers for corneal 
endothelial cell therapy. These could efficiently deliver the cell sheet transplants at the site of 
injury220. Lawrence et al. reported that silk protein films could support corneal cell functions and 
were used to reproduce corneal stromal tissue building221. Dual layer scaffolds were prepared from 
Silkworm (Bombyxmori) silk fibroin for corneolimbal reconstruction of diseased or damaged 
ocular surface. These fibroin membranes showed potential as a substrate for human limbal 
epithelial (L-EC) and limbal mesenchymal stromal cell (L-MSC) cultivation222. Porous silk fibroin 
film were synthesized by mixing of silk fibroin and poly(ethylene glycol) (PEG) followed by the 
removal of PEG from porous films. These films were used as biocompatible carriers to deliver 
corneal epithelial cells to ocular surface223. 
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Klenkler et al. modified polydimethylsiloxane (PDMS) surfaces with epidermal growth factor 
(EGF) to improve the growth of corneal epithelial cells224. The design of artificial limbal stem cell 
niches for cell delivery to cornea was explored by the fabrication of biodegradable poly(lactic-co-
glycolic acid) 50:50 electrospun membranes225, which have the potential to support the growth of 
limbal epithelial cells for periods of at least of 2-3 weeks in culture226, 227.  Biodegradable PLGA 
membranes containing micro-pockets mimicking an ex vivo 3D cornea model can potentially 
contribute to the migration of limbal cell from limbal explants 228, 229,230. Fig 9 reveals degradation 
of PLGA membranes when placed in media with and without cells and showed that fibres lost 
LQWHJULW\RYHUZHHNV¶WLPHPoly (2-hydroxyethyl methacrylate) (PHEMA) hydrogels were used 
for functional polymeric artificial corneas (keratoprosthesis)231.Optically transparent, 
biocompatible and biodegradable poly(ethylene glycol) (PEG)-based hydrogel films (PHFs)  
appeared  good candidates for regeneration and transplantation of corneal endothelial cells (CECs) 
by Ozcelik et al232. 
(Insert Figure 09) 
 
 Recently, much attention has been dedicated to the use of blends of biodegradable polymers to 
get interpenetrating polymer networks (IPNs). These hydrogels showed better mechanical 
properties and harnessed greater multi-functionality appropriate for keratoprosthesis233. A number 
of researchers have investigated the synthesis of poly(ethylene glycol)/poly(2-
hydroxyethylmethacrylate) (PHEMA)-based IPN hydrogels and chitosan±PCL-blended 
membranes as carrier for corneal endothelial cell (CEC) transplantation234,235. A number of studies 
have been reported on the pros and cons of using polymers such as collagen and fibrin based carrier 
materials in limbal stem cell deficiency (LSCD) remedy204. In 2010, recombinant human collagen 
type III (RHCIII) hydrogels that facilitated nerve regeneration and stromal cell were developed as 
corneal constructs. Although promising, these implants presented some limitations, including 
sufficient cell division speed to evade infection and fibrosis in some cases.236 This data identifies 
the need to develop corneal implant that can be accurately grafted and in parallel allow rapid 
healing process. Recent studies have highlighted the importance of post fabrication remodelling in 
achieving positive clinical outcome237. 
Collagen and phospholipids are being used to construct corneal implants that can be further 
specifically functionalized using printing and laser profile techniques. In a recent study, 500µm 
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RHCIII±MPC hydrogels were fabricated using 2-methacryloyloxyethyl phosphorylcholine (MPC) 
that promoted fibronectin printing. The micro-patterns of 30µm size generated in these RHCIII±
MPC hydrogels showed optimal mitotic division and cell attachment. In vivo studies have yet to 
replicate these properties exhibited by RHCIII±MPC hydrogels238. Biomaterials owing to their 
therapeutic properties have shown promising avenues in corneal repair and regeneration. At 
present, research is being focused on corneal regeneration in vitro and in vivo using polymer 
(gelatine, alginate and chitosan) based hydrogels, and constructs239. A recent study has shown that 
primary human corneal keratocytes were more compatible with silk fibroin films fabricated by 
centrifugal force. Bombyx mori cocoons were used to retrieve silk fibroin (SF). SF has been used 
in corneal tissue engineering and approved by FDA for soft tissue repair. SF films prepared by 
centrifugal force had smooth surfaces, transparency and elasticity, rendering favourable 
environment for cell growth240. 
3.6- Dental and Oral Structure         
The basic knowledge about the biology of the oral and tooth structure as well as the information 
about fundamentals of materials and techniques applied to tissues, constitute the basis for 
restorative dentistry and help in creating biological approaches to tissue regeneration. A suitable 
inductive carrier is essential for dental-pulp tissue regenerative treatment. The selection of suitable 
scaffold has vital importance to persuade and confer the optimal formation of new dentin matrix 
and pulp-dentin complex27. For regenerative dentinogenesis optimal conditions for cell adhesion, 
migration, proliferation and differentiation must be provided. Among dental problems, periodontal 
diseases are highly prevalent and 90 % of the worldwide population is affected. Periodontitis is 
one of the periodontal diseases leading to loss of connective tissue and bone support, which is a 
major cause of tooth loss in adults241. The techniques, such as bone graft, guided tissue 
regeneration (GTR), and stem cell therapy have been used for periodontal tissue regeneration, 
among these the GTR has become the most promising treatment and has been widely used in 
clinical treatment for its convenience and effectiveness242. During GTR technique a barrier 
membrane provide mechanical support to gingival connective tissue on one side and periodontal 
ligaments on other side243. The first generation these membranes comprised of stable, non-
immunogenic polytetrafluorothylene (ePTF), a non-resorbable material. However, the significant 
drawback is related to the risk of disturbing healing with the second surgery necessary to remove 
the permanent. To address this issue, a second generation of resorbable membranes was developed. 
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The resorbable membranes can potentially provide better healing as the material resorption and 
bone ingrowth occur simultaneously. Recently, third generation of membranes have been 
introduced with bioactivity244. The basic principal of GTR membrane is to restore the architecture 
and functionality of the periodontal system245. On the basis of this, the ideal periodontal membrane 
should have two important properties i.e. stiffness and elasticity246. Various types of materials have 
been tested for their effectiveness as barriers including non-degradable and biodegradable 
membranes247. A list of commonly used commercial periodontal membranes is given in Table 1.  
 
(Insert Table 1) 
 
Several problems have been associated with the use of non-degradable barrier membranes, 
particularly the need for a secondary surgery to remove the membrane. Furthermore, early 
exposure to the saliva present in oral environment and subsequent bacterial colonization are 
common problems resulting in early detachments. To overcome these issues, a variety of synthetic 
biodegradable materials, such as polylactide, PLA, PCL, and their copolymers or tissue-derived 
collagens have been used as membrane barriers248-251. It is suggested that a highly hydrophobic 
surface, which act as a non-conductive towards protein attachment, should be used an occlusive 
barrier for gingival epithelial cells in periodontal regeneration. The schematic structure of 
periodontal membrane is given in Fig. 10 252.  
(Insert Figure 10) 
 
Drug loaded biodegradable periodontal membranes were synthesized and found that non-steroidal 
anti-inflammatory drugs can create an effect on morphology of electrospun fibers and smooth 
electrospun fibers can be achieved with high drug loaded polymers. Moreover, doxycycline based 
periodontal membranes stimulated cell proliferation and osteogenesis253-255. Kasaj et al.256 
evaluated the biological effects of various commercially available biodegradable membranes made 
of collagen and compared it with non-degradable membranes in cultures of human gingival 
fibroblasts, periodontal ligament fibroblasts and human osteoblast-like cells. It was found that non-
degradable membranes limited the cell adhesion and the biodegradable membranes demonstrated 
to be more suitable to stimulate cellular proliferation compared to non-resorbable membranes as 
shown in Fig 11. 
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 (Inset Figure 11) 
Chen et al.,257  fabricated biodegradable electrospun PLLA/chitosan membrane synthesized by 
aminolysis method for periodontal regeneration. The membrane was aminolyzed with chitosan to 
enhance the biocompatibility. The modification of chitosan can promote the hydrophilicity, 
bioactivity, and degradation rate of PLLA electrospun membrane. The degradation rate of PLLA 
scaffold increased significantly after chitosan grafting, which was due to introduction of imine 
groups (±CH=N±) on PLLA fibres through the modification. The hydrolysis of imine and ester 
groups led to the degradation of PLLA-CS, which resulted in additional mass loss, while the PLLA 
degradation was mainly caused by the hydrolysis of ester groups258. During the aminolysis process, 
the alkaline catalysed degradation of PLA matrix resulted in a decrease of molecular weight259. In 
vitro degradation study showed that modified membrane (PLLA-Chitosan) degraded quickly 
compared to pure PLLA and the quantitative analysis showed that after 6 weeks PLLA-Chitosan 
degraded 20%, whereas pure PLLA showed only 5%.  The SEM micrographs (Fig. 12) show the 
degradation behaviour of electrospun fibres of modified and pure degradable polymers after 2, 4 
and 6 weeks. The modification of imine group (-CH=N-) with PLLA enhanced the degradation 
process, however, the main degradation was due to the hydrolysis of ester group.  
 (Insert Figure 12) 
In same study, cell culture showed that the modified membrane had a better biocompatibility and 
promoted cell (MC3T3) proliferation compared with pure PLLA and tendency to prevent 
fibroblast invasion257. Fig. 13 shows the optical and fluorescence image of PLLA-chitosan 
membrane after culturing of fibroblast NIH 3T3 on surface and it was observed that after 5 days, 
the fibroblasts were on top of the electrospun membrane.  
 (Insert Figure 13) 
The poor biocompatibility of pure PLLA was due to the absence of natural recognition sites on 
polyester surfaces for covalent cell recognition signal molecules, whereas chitosan mimics extra 
cellular matrix and facilitate the cells to grow and help in functioning. The polyester-based 
membranes are biocompatible, biodegradable, and easier to handle clinically as well as allowing 
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tissue integration. Their degradation rate is important as these membranes must function for at 
least 4±6 weeks to allow successful regeneration of the periodontal system260. Generally, the 
biodegradation of these polyesters involves non-enzymatic cleavage of PGA and PLA into pyruvic 
and lactic acids, respectively, which are common end-products of carbohydrate digestion. Milella 
et al.261 evaluated both the morphological and mechanical characteristics of commercially 
available polyester-based membranes. It was observed that the membranes demonstrated initially 
high strength (12±14MPa), losing their structural and mechanical properties within 4 weeks of 
incubation in culture medium. The maximum strength after 14 days of exposure decreased 
significantly (below 1MPa). Collagens are important alternatives to synthetic polymers in 
GTR/GBR procedures due to their excellent cell affinity and biocompatibility. However, type I 
collagen may have limitations in its use due to the high cost and poor definition of its commercial 
sources, which make it difficult to control degradation and mechanical properties. Collagen-based 
membranes have shown very poor performance in vivo as the membrane starts to degrade. The 
breakage and fragmentation of collagen fibrous membranes started after 7 days of incubation and 
after 30 days, the degradative behaviour enhanced, and pores were evident as shown in Fig. 14.  
(Insert Figure 14) 
Additionally, the risks of disease transmission due to the use of human- or animal-derived collagen 
may pose regulatory or other limitations, such as religious beliefs, on its use. Biomechanical 
properties and collagen matrix stability can be enhanced by means of physical/chemical 
crosslinking, by ultraviolet (UV) radiation, genipin (Gp), and glutaraldehyde 261, 262. It was 
proposed that a natural polymer based membrane has better cell adhesive and biocompatibility 
properties; however, its mechanical strength is not up to the mark. In contrast, synthetic polymers 
have desirable mechanical properties, but poor biological properties. Therefore, modifying natural 
polymers, such as collagen membranes with synthetic polymers may yield GTR barrier membranes 
with optimal properties. PLA, poly(glycolide-co caprolactone)(PGC) and PLGA was employed 
and spray coated on collagen membrane which significantly improved its mechanical strength263. 
To date WKHFKLWRVDQPHPEUDQHV¶DSSOLFDWLon is still in the animal assay phase, but the results 
showed great potential for chitosan materials in GTR procedures. In comparison to other 
biodegradable membranes, the chitosan membranes are cheaper and possess better tissue healing 
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effect and showed more cementum and bone formation in animal models. The bacteriostatic 
property of chitosan may reduce the bacterial contamination and enhance periodontal tissue 
regeneration. The degradation rate of chitosan membranes manufactured by different methods was 
evaluated in a number of studies264, 265. Pure chitosan membranes degraded by about 15±40% of 
their initial weight after 90 days shaking in phosphate buffer saline (PBS). In vivo testing showed 
that after grafting into rat subcutaneous tissue chitosan membranes maintained their shape and 
space for bone regeneration for 6 weeks266. The degradation rate of chitosan membranes depends 
on their molecular weight and the preparation methods, and it fit into the schedule of remodelling 
of tissue regeneration267. 
 
3.7- Trachea         
Patients suffering from damage of the trachea after tumour formation of excision need permanent 
treatment 268, 269.  However, this is a major challenge, in part due to the specialised structure of the 
tissue.  The trachea is a circular segmented architecture of cartilage, interconnected with soft 
tissues to form the tubular air pipe structure of the respiratory system270. The main function of this 
fragmented cartilage is to provide sufficient stiffness and flexibility to regulate airflow 
systematically. Tracheal anatomy reveals an inner surface of columnar epithelium, with cilia that 
help in trapping extraneous air particles together with goblet cells for exuding mucus to form 
protection against any external stimuli268. These functions are unique and cannot be modelled 
through autologous tissue implants. Therefore, tracheal regeneration271 is a focus of many 
biomedical engineers and clinicians. The on-going research in tracheal regeneration uses 
prosthesis implants, synthetic composites and tissue-engineered constructs271-273. But these 
biomimetic materials are associated with clinical issue e.g., breath impediment, infection and 
dehiscence, limited epithelialization and vascularization. Tissue engineering strategies274 are not 
yet able to produce an ideal tracheal implant. Nonetheless, TE holds the potential to realize 
advanced and optimal tracheal grafts29, 275, 276 while considering the following factors such as: (a) 
the graft should be biodegradable and biocompatible (i.e. it can offer a suitable architecture for 
cells so they can produce cartilage and soft tissue of the apposite cylindrical contour.) (b) It should 
stimulate epithelial development (i.e. it has a well-designed epithelial lining that could either be 
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cultured or migrated from the native trachea), and (c) should facilitate adequate vascularization, to 
support the volume of tissue required for clinical application269. 
The first tracheal tissue engineered product was introduced by Vacanti et al277, who reported a 
three-dimensional tracheal scaffold prepared from synthetic nonwoven mesh, 100µm thick PGA 
fibres (15µm in diameter, cut into pieces of 2.5 x 4cm) for replacing large circumferential cervical 
defects in trachea of rats. Chondrocytes were seeded into engineered cartilage to evaluate their 
viability, the scaffold allowed the expansion of chondrocytes. Implantation of cell-polymer 
constructs was reported to produce hyaline cartilage after four weeks in mice. Follow-up 
histological studies showed that from initial stage samples, an identical cartilage to the natural one 
was produced, but later the animals suffered from respiratory distress and ultimately died. The 
collapse of cartilage was supposedly by non-optimized mechanical properties 269, 277. In another 
study by Kojima et al278, they used biodegradable PGA non-woven mesh enfolded in a helical 
template composed of silicone rubber. For in vitro studies, chondrocytes and epithelial cells were 
isolated and seeded from sheep nasal septum. The cell-polymer construct was implanted into 
subcutaneous pockets of nude mice. After six weeks of cell growth, epithelial cells were suspended 
in hydrogel and infused into the implanted tissue construct. Hemotoxylin and eosin staining 
demonstrated full-grown cartilage, pseudostratified columnar epithelium growth and a separate 
interface or borderline, connecting tissue-engineered cartilage and epithelium. Furthermore, 
Safranin-O staining results illustrated ordered circular lobules and angular lacunae respectively, 
which contained single chondrocytes. The authors concluded that the morphology of the implants 
resembled native sheep trachea in that the proteoglycan and hydroxyproline content was similar to 
native cartilage, and therefore had the potential for regeneration of segmental tracheal defects as 
well as epithelial formation.   
Despite the reported success in tracheal restoration by implantation of tissue engineered constructs 
and transplantation procedures, none of the newly established techniques have resulted in clinical 
application on a large scale. Developing or regenerating a purposeful tracheal tissue from different 
cultured cell types is still a major challenge for researchers279. For instance, tracheal fixation in 
laryngectomized patients and prosthetic voice rehabilitation using tracheoesophageal silicone 
rubber speech valves and tracheostoma valves has resulted in many complications. Furthermore, 
animal models used for tracheal research vary widely and in most of the cases, proper scientific 
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justification for choice of animal is not explained. These issues play a decisive role in tissue 
engineering and are thoroughly discussed in a review paper by Hallers et al279.  
With the passage of time, several progressions in tracheal tissue engineering have been made271. 
Rotter et al.280 demonstrated the effect of interleukin in tissue-engineered cartilage made from 
PGA±PLA (PGLA) matrixes. PGLA scaffolds seeded with porcine auricular chondrocytes and 
unseeded scaffolds as controls were implanted in an autologous immunocompetent pig model. 
Histological studies by using haematoxylin and eosin, SafraninWULFKURPHDQG9HUKRHII¶VVWDLQLQJ
and biochemical studies confirmed that the level of glycosaminoglycan showed acute 
inflammation. Moreover, homogeneous cartilage development was not observed in any of the 
samples except in specimens taken after one week of implantation. Furthermore, histological 
studies revealed acute inflammation around the degrading scaffold, whereas, glycosaminoglycan 
contents were observed considerably higher in serum free group. These are regarded as inhibiting 
factors in regeneration of cartilage tissue. Scaffold free cartilages have also been proposed in the 
literature by Wu et al. 281 and Weidenbecher et al.282  respectively. Wu et al fabricated cylindrical 
cartilage using a chondrocyte macro-aggregate. In another study, Weidenbecher et al. developed 
scaffold-free cartilage sheets for fabricating a vascularized neo-trachea in a rabbit model. A 
tracheal framework was produced by these neo-tracheal tissue engineered constructs after few 
weeks of harvesting and these neo-tracheas, healthy with well-vascularized supported with 
integrated layers, but showed limited mechanical strength, thus were unable to reinstate segmental 
defects and long-term patency in trachea281, 282. In another study283, composite grafts were 
fabricated from a biodegradable 3-layered scaffold: a collagen sheet, a PGA mesh, and a 
copolymer (L-lactide/ܭ-caprolactone) coarse mesh. Chondrocytes isolated from the auricular 
cartilage of New Zealand white rabbits were cultured and then seeded onto the biodegradable 
construct to restore tracheal stenosis. Implantation was carried out in a mid-ventral defect of 
cervical trachea. In addition, a gelatine sponge for an appropriate supply of basic fibroblast growth 
factor (b-FGF) on scaffold was also employed. Their findings showed that the biodegradable 
scaffold was able to regenerate the tracheal architecture up to 3 months after implantation. 
Regardless of their success, authors proposed further studies that may establish techniques that 
could facilitate homogeneous cartilage formation with optimal functional and mechanical 
properties283.  
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Lin et al.284 reported a unique approach, as they developed a scaffold based bioreactor system for 
tissue-engineering of trachea under the influence of controlled fluid flow. A scaffold of poly (3-
caprolactone)-type II collagen was seeded with chondrocytes and grown under controlled 
rotational speed/fluid flow and resulting shear stress in the bioreactor. This procedure enhanced 
cell proliferation, glycosaminoglycan (GAG) and collagen content in the constructs compared to 
static culture for the same time. For instance, at a rotation of 15 rpm, a two-fold increase in cell 
population, 170% increase in GAG content and 240% increase in collagen were achieved. H&E 
staining provided evidence of neo-cartilage formation along with aligned chondrocytes in direction 
of fluid flow. 
The potential of using transplanted cells from the patients was also carried out by Kobayashi et 
al.285. They used synthetic grafts of collagen sponge containing a spiral polypropylene stent and 
mesh in combination with gingival fibroblasts (GFBs) and adipose-derived stem cells (ASCs) as 
autologous transplanted cells for tracheal epithelial regeneration. Their studies revealed limited 
risk of rejection by immune systems and contamination from allotransplant cells but showed 
sluggish epithelial regeneration285. Tatekawa et al.286 reported on the use of a bio absorbable 
copolymer of caprolactone-lactide sponge sheet reinforced with a poly(glycolic acid) fibre mesh 
(Cop). Cop incorporated gelatine hydrogel and Cop-gelatine hydrogel with basic fibroblast growth 
factor were used with an external non-degradable polymer stent. Implantation was carried out in 
three groups of rabbits and tracheal epithelialization, cartilage formation and vessels were only 
noticed in bio absorbable copolymer containing gelatine hydrogel (Figure 15).  
 
 (Insert Figure 15) 
 
Their observations revealed that respiratory distress, loss of appetite airway resulted in tracheal 
collapse as well as dislocations of the copolymer (due to mucosal sloughing) were the reasons of 
rabbit death. To overcome this situation and to retain long-term survival, the reconstructed trachea 
was reinforced by external stenting on either side of the trachea286. Interestingly, macromolecules 
such decorin, a proteoglycan (PG) residing in the complex network of ECM proteins of connective 
tissues, have also been explored for tissue engineering applications287. Hinderer et al287 introduced 
a strategy in which decorin was electrospun in 3D fibrillary scaffolds fabricated from 
biodegradable PCL-gelatine matrices for tracheal tissue regeneration. The electrospun scaffolds 
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were investigated for cell-matrix-interactions and immune-mediated mechanisms and found low 
immunogenicity for hPAEC (human primary airway epithelial cells) expansion as shown in Figure 
16. Their findings revealed possible applications in restoration of the trachea by these functional 
3D hybrid scaffolds287.  
 
(Insert Figure 16) 
 
Different strategies have been executed to advance existing research development in tissue 
engineering of the trachea272, 275. One such recent example is engineering of a vascularized trachea 
by utilizing   bioresorbable PLGA and PCL scaffold269. In this study, implanted scaffolds were 
wrapped with pedicled muscle flap over a ring-shaped mould. Furthermore, these muscle enfolded 
PLGA and PCL scaffolds were seeded with chondrocytes, bone marrow stem cells and co-cultured 
both cells respectively. Implantation of these engineered scaffolds was done as an ectopic culture 
over abdominal wall of rabbits and harvested for several weeks. The tissue engineered constructs 
were harvested after subsequent in vivo intra-muscular incubation. It was observed that all the 
scaffolds preserved adequate cylindrical contours for two weeks. Though, harvesting after four 
weeks, contraction and deformation in the PLGA scaffolds was observed. After careful detachment 
of a silicone mould and muscle tissue, a well-encapsulated ring of PLGA and PCL scaffolds were 
further investigated as shown in Figure 17a. Structural similarities among tissue engineered 
scaffolds and to native cartilage were evident in PCL scaffolds at the two-observation time-points. 
Whilst the PLGA scaffolds after four weeks had shrunk and deformed, those at two weeks had not. 
In addition, a considerable weight loss (22.5%) of PLGA at four weeks was observed, compared 
to weight loss of PCL at 2 weeks (6.3%) (Figure 17b). Hence, PCL tissue engineered scaffolds due 
to their adequate porosity maintained tubular scaffold geometry and were considered as more 
suitable for intra-muscular tracheal tissue engineering as compared to PLGA scaffolds. 
Histological results further revealed that PCL engineered scaffolds exhibited optimal 
chondrogenesis with sufficient stiffness to maintain the cylindrical shape and luminal patency 
comparable to the native trachea. 
 
(Insert Figure 17) 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
37 
 
3.8- Bones         
Bone tissue is a naturally occurring nanocomposite comprising of organic-inorganic molecules 
compacted together. It consists of a nano-crystalline, rod-like (25-50 nm in length) inorganic 
ceramics such as hydroxyapatite (HA) {Ca10(PO4)6(OH)2}288 embedded into collagen fibrils with 
osteoblasts, osteocytes and osteoclasts as cell components289-291. Nowadays, synthetic HA has been 
used in bone regeneration due to its cytocompatibility as well as good osteoinductive and 
osteoconductive abilities292, 293 &RPPHUFLDO +$ DQG ȕ-tricalcium SKRVSKDWH ȕ-TCP)-based 
ceramic products are used for bone repair, augmentation and replacement, or as fillers in bone and 
teeth, as well as coatings of orthopaedic and dental implants. However, due to their low mechanical 
or tensile strength and fracture toughness as compared with natural bone, slow biodegradability in 
vivo and limited interactions with osteogenic proteins either restrict its use in load-bearing 
applications or reduce its efficiency in bone tissue regeneration. With the advent of 
nanotechnology, new horizons in the scientific and industrial research have been accomplished. 
Research at the nanoscale level enhanced the structure property relationship especially for 
biomaterial in tissue engineering. HA has been modified and toughened with polymers294, silicon 
carbide295, alumina296 and titanium materials297. Biodegradable polymers have been explored with 
HA and a variety of other nano-porous materials 298-300. HA-PLGA nanocomposite material have 
been developed which possesses good osteogenic activity290. Bone morphogenetic proteins, such 
as BMP-7 derived DIF-7c peptide were chemically functionalized onto nano-HA and integrated 
within the nano-phase of hydroxyapatite-PLGA composite, pristine PLGA and mixed directly into 
cell culture medium. Experimental studies revealed that HA-PLGA nano composites promoted 
hMSC adhesion in contrast to pristine PLGA. It was also notable that osteogenic differentiation of 
hMSCs by nano-hydroxyapatite and nano-hydroxyapatite-PLGA composites was appreciable as 
compared with direct injection of the DIF-7c peptide into culture media. In a recent study, Chitin-
PCL-nHAp (nano-hydoxyapatite) based injectable microgels were prepared for healing major 
bone defects301. It has been observed that addition of nHAp in polymer matrix enhances the 
mechanical properties. However, biological characteristics of the composite microgels supported 
material cytocompatibility and protein adsorption. Furthermore, cell culture studies in chitin-PCL-
nHAp microgels with adipose derived mesenchymal stem cells (rASCs) from rabbit showed good 
expressions of alkaline phosphatase, osteopontin, osteocalcin, as well as, migration of rabbit 
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adipose derived mesenchymal stem cells (rASCs). Consequently, chitin-PCL-nHAp microgels 
could offer an effective injectable material for regenerating a diverse variety and complex bone 
defects301.  
In recent years, synthetic biodegradable polymers and their composites have been tuned to 
fabricate well-aligned and multipurpose tissue engineered constructs 12, 33, 34, 52, 79, 244, 288, 291, 302-308. 
In a recent study, fibre based biodegradable scaffolds302 such as poly-1-caprolactone/polylactic 
acid (PCL/PLA) composites, containing fibres of PLA in a PCL matrix were developed in cell 
instructive scaffold fashion for investigating bone osteogenesis. Integration of PLA fibres into the 
PCL matrix resulted in drastic improvement in mechanical properties. The most interesting aspect 
of this research is computational fluid dynamic models, which expose the material's capability to 
exert hydrodynamic forces during in vitro cell culture, as a result, an optimal flow rate was 
established that enabled specific cellular event to happen. e.g. osteoblast differentiation from 
hMSCs. 
Some natural biodegradable materials, such as collagen, gelatine and silk have also been used in 
combination with other materials306. Nevertheless, formation and significance of anti-bovine 
collagen antibodies in many human recipients containing bovine collagen is still a matter of debate 
and not yet fully understood79. Therefore, numerous biodegradable polymers and their composites 
have been investigated to make hybrid tissue scaffolds for bone and cartilage regeneration 302, 309. 
Such nanomaterials have remarkable characteristics, such as cell adhesion, interaction and 
proliferation as compared to the pure synthetic polymers. Collagen has also been used to improve 
cell interactions with electrospun nano-fibres of bioresorbable PLA, PGA and PCL and their 
copolymers 79, 309-311. Composite biomaterials from biodegradable PLA, PGA and their copolymer 
PLGA have been employed with bioactive ceramics i.e., bioactive glass particles or HA8. Studies 
showed that such materials stimulate bone regeneration, as well as, offer better mechanical strength 
and biological concert303. It was also reported that composites of polymers and Bioglass® are 
angiogenic i.e., they supported the growth of blood vessels, suggesting a novel approach for 
providing a vascular supply to implanted materials in bone tissue engineering, which was 
confirmed by histological studies of resected implants (Figure 18312).  
(Insert Figure 18) 
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Composite biomaterials from natural, synthetic polymers and nanomaterials are also been used 
extensively34, 291, 305-308. This includes biomaterials based on gelatine and silk derivatives which 
have been studied recently. Due to their biological source, biocompatibility, excellent 
biodegradability and above all its ease of availability at low cost, makes them suitable for tissue 
engineering313, 314. A number of this class of biomaterials, such as gelatine methacrylate 
(GelMA)28, interpenetrating GelMA-SF (silk fibroin)28, silk±silk composite scaffold315 and CNTs 
reinforced GelMA composites material316 have been employed in tissue engineering applications. 
All these materials have intrinsic benefits and limitations, such as preparing GelMA is low cost 
and convenient and it also promotes cell proliferation, migration, natural cell binding and 
degradation motifs but its use has become limited when rapid degradation is required, or high 
mechanical stiffness cannot be compromised. In GelMA-SF, SF addition to GelMA system 
increases physical cross-linking without any chemical modification. Both these factors, such as 
crosslinking and crystallinity, influence the mechanical and degradation properties of these 
material28. However, the biocompatibility of silk and its ability to form large porous structures 
offers a significant advantage and it has been further investigated to fabricate silk-silk macro 
porous scaffolds315. The high interfacial cohesion between SF and macro particles resulted not 
only in reinforcing mechanical properties but also lowered or restricted the enzymatic degradation 
of the scaffolds. Use of carbon nanotubes (CNTs) in GelMA also reinforces the mechanical 
stability due to interaction between peptide chain and CNTs316. Cross-linking was not observed 
resulting in a significant dispersion in the medium.  
In preparing an optimal bone graft, the efficiency of materials can also be enhanced by increasing 
their surface area as can be achieved by producing nanostructures and subsequent functionalization 
by incorporating nano-fillers in the polymer matrix. For this purpose, an ideal material would 
instruct mechanical stability to the composite without reducing its bioactivity. In this perspective, 
one and two dimensional carbon based materials with high chemical inertness and good 
biocompatibility, such as carbon nanotubes (CNTs), graphene or graphene oxide (GO) can help in 
enhancing the physical, chemical and biological properties of biomaterials for bone tissue 
engineering290. Recently, CNTs290, 316-318 and GO290, 317, 319, 320have been used as nanofillers and 
reinforcing agents in synthetic and natural biodegradable polymer matrixes for bone regeneration 
and tissue engineering applications321, 322. Interestingly, in every case, these nanostructures 
resulted in improved physical properties, such as resilience, toughness and tensile strength, as well 
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as good biocompatibility and biodegradation. In addition, no obvious toxic effects in vivo215, 317, 
323
 were observed. Hence, these types of biomaterials offer great potential in tailor making required 
properties when incorporated in polymeric materials, ultimately strengthening material properties 
without offsetting its bioactivity/biocompatibility and allowing to be used for bone regeneration215, 
317
. In terms of its biological efficiency, graphene offers cell adhesion and proliferation i.e., for 
osteoblasts319, 324, 325. Furthermore, during tissue formation electrical stimulation of osteoblasts can 
be carried out utilising superior electrical conductivity of graphene326. Besides graphene, graphene 
oxide also exhibits promising biological properties by facilitating adhesion and proliferation of 
mouse fibroblast cells 327, providing drug delivery platforms for water insoluble cancer drugs328 
and in biosensors329. Its multifunctional reinforcing properties in polymer/nanocomposites have 
led to the development of synthetic materials with significantly enhanced mechanical strength330, 
331
. 
 
Incorporating GO in natural or synthetic polymers are a very effective method for preparing 
graphene based polymer nanocomposites. Since GO contains abundant oxygen-containing groups 
e.g. hydroxyls, epoxides, diols, ketones and carboxyl on its surface330, these can promote 
interfacial interactions with other materials. Furthermore, it is observed experimentally that by the 
addition of very minute amounts, (e.g. 1wt% of GO in polymer matrix) lead to a significant 
increase in their physical properties. In a recent study, the reinforcing effects of GO in a gelatine 
matrix have been studied in detail, in particular the size and morphology of GO sheets, the degree 
of dispersion of the GO sheets in gelatine matrix and the interactions of two phases. Results 
obtained in this study indicated that in gelatine-GO composites, an enhancement of the mechanical 
properties (tensile strength, Young's modulus and energy at break) of gelatine increases by 84%, 
65% and 158%, respectively just by addition of 1 weight% of GO. Furthermore, bio mineralization 
and biocompatibility of gelatine was also enhanced. In spite of these attributes, moisture sensitivity 
and toughness314, use of gelatine based materials for bone tissue engineering have been limited. 
Chitosan and epoxy based materials have also been used, but most of the GO-polymer composites 
reported in literature exhibit reduced ultimate strain or toughness330, 332, 333 so their use as bone 
substitutes have been limited to date.  
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4- Future Perspectives          
In tissue engineering, several biodegradable materials have been examined for organ specific 
regeneration, as discussed in the relevant sections within this review. Their success totally depends 
upon the clinical requirements, their physical and biological compatibility with the host tissue as 
well as various environmental factors. Therefore, extensive research is required to meet the desired 
goals. For instance, in the case of skin a variety of commercially available skin substitutes are 
present in order to regenerate skin and to regain its normal structure and function. However, it is 
obvious that the ideal skin substitute does not exist. The factors hindering implementation of 
currently available skin substitutes have low mechanical properties, lack of biocompatibility, 
minimal structural differentiation, limited vascularization and scar development88, 97. Over the last 
10 years, tissue-engineering research has been conducted for every important tissue and organ of 
the body. Hence, optimization of tissue-engineering techniques, including cell harvesting, culture, 
expansion, as well as polymer material design are prerequisites for success prior to clinical 
exploitation, as a result of which numerous advancements in regeneration of trachea269, 287, 334, 335 
and bone336-341 have been established. There is however still the need to fabricate organ specific 
materials and ideal tissue substitutes that can support the regeneration of specific biological tissues. 
These applications may also include targeted utilization of the resources e.g. biomaterials, cells, 
tissue, growth factors aimed at either engineering a specific tissue or re-growth of a damaged 
tissue/organ. Furthermore, development of a physiologically appropriate bioreactors is also 
essential for tissue regeneration, specifically when tissue engineering is carried out for a complex 
organ by fabricating tissue engineered constructs and trialled prior to implantation in humans. 
Neovascularization is highly desirable process for almost all of tissue engineered products to 
survive 342. The blood vessels supply food and oxygen when scaffolds have been applied to keep 
them alive. However, to date, the main focus has been on tailoring biocompatibility, mechanical 
properties or other related characteristics and limited efforts have been carried out to build their 
angiogenic properties. There is an immediate need for the development of angiogenic 
biodegradable materials for tissue engineering. Currently a number of strategies including use of 
growth factors343, 344, stem cells345 and biomolecules (e.g. heparin346) are being investigated to find 
their role in future tissue engineered commercial products. In addition, there has been significant 
interest to develop smart functional materials exhibiting conductive, magnetic and optical 
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properties. In this regard, the macro- and nanotechnologies have been found to be effective 
fabrication tools for the manufacturing of such materials. No doubt the stimulus-responsive 
materials having ability to tailor their properties to specific requirements are the most desired 
biomaterials for tissue engineering community. For this purpose biocompatible conductive 
polymeric materials are considered to be the materials of interest and such materials are already 
being used in fuel cells, electronic devices including capacitors and energy storage devices and 
these appears to be promising materials for tissue engineering applications as well.  
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List of Figure captions 
 
1. Figure 1: Rate order of hydrolytic degradation of chemical functional groups present in 
commonly used synthetic polymers.  
2. Figure 2 (A) Enzymatic degradation patterns of chitin; (B) Endo-hydrolysis by 
chitosanase in chitosan; (C) Mammalian hyaluronidases (EC# 3.2.1.35) catalyzed 
degradation of hyaluronic acid; (D) The amino acids glycine, proline and 
hydroxylproline base triple helix region which cleaves as a result of collagenases action.  
3. )LJXUH%XUQYLFWLP¶VZRXQGVKHDOLQJE\ using tissue engineered skin. (A) Wound 
KHDOHGE\XVLQJSDWLHQW¶VRZQNHUDWLQRF\WHVDQGILEUREODVWVJURZQLQWKHODERUDWRU\
(B) wound after two months of surgery. (Ref 90= Reused with permissions, Copyrights 
@Springer Nature) 
4. Figure 4 :(a) Appearance of wound prior to application of apligraft; (b) application of 
apligraft; (c) appearance of wound after application. (Reprinted as an  open access for 
unrestricted noncommercial use 96. 
5. Figure 5. Tissue engineered skin in :( A) melanocytes can be seen in dermis; (B) 
showing the effect of combining fibroblasts and melanocytes on pigmentation. (Ref 90= 
Reused with permissions, Copyrights @Springer Nature) 
6. Figure 6. Application of Biobrane. a). Before application b). After 
application(Reprinted as an  open access for urestricted non commerical use108. 
7. Figure 7:ASC-based cell therapy for a case of acute skin necrosis in the nose dorsum 
due to inadvertent arterial injection of hyaluronic acid (HA) filler: (A) Before stem cell 
therapy (seven days after HA filler injection); (B) Three weeks after stem cell 
therapy.(Reprinted as an open access for urestricted non commerical use)126 
8. Figure 8: Effects of scaffold composition and architecture on the morphology, 
alignment and elongation of CFs. (A) F-actin filaments and nuclei stained CFs with 
phalloidin and DAPI on the random and aligned scaffolds. Main panels indicate the 
orientation and morphology of cells. Insets: higher magnification images showing 
elongated stress fibers within the cells cytoplasm increasing with lower PGS content. 
Quantified (B) alignment and (C) elongation of CFs on each scaffold. Cell alignment 
was significantly higher on A(PGS:2Gelatin) scaffold compared to A(Gelatin)scaffold 
(*: P< 0.05). (Adapted from 186 Elsevier). 
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9. Figure 9. Breakdown of PLGA membranes over 6 weeks. In these experiments 
membranes were placed in culture media and their morphology and mass examined 
over 6 weeks. A shows SEM of the fibres of non-sterilised and g-irradiated for 44 
kg/mol and 153 kg/mol of PLGA over 6 weeks. B shows the visual appearance of g-
irradiated PLGA (molecular weight 44 kg/mol) over 6 weeks when cultured with rLEC 
cells. Membranes plus cells are shown on glass coverslips. C shows percentage weight 
loss of the membranes both nonsterile and g-irradiated comparing low (44 kg/mol) and 
high (153 kg/mol) molecular weight membranes over 6 weeks of culture with rLEC 
cells. ( adapted from reference 230 Elsevier)  
10. Figure 10. Schematic structure of periodontal membrane (Redraw from Sheikh et 
al).252 
11. Figure 11. SEM images showing the cell adhesion on degradable (a-c) and on non-
degradable (d-f) polymeric network and images confirmed that more cell adhesion was 
found on degradable polymers (Courtesy from Kasaj et al).256  
12. Figure 12. The images showing PLLA-Chitosan modified electrospun fibers (a) before 
immersion, (b) after 2 weeks immersion in PBS, (c) 4 weeks and (d) 6 weeks (Courtesy 
from Chen et al).257 
13. Figure 13: Presence of fibroblast on top surface of PLLA-chitosan electro spun 
membrane after 5 days culturing (courtesy from Chen et al). 257 
14. Figure 14. SEM images of collagen membrane (a) surface analysis, (b) after 30 days 
incubation in DMEM at 100x, and (c) at 1000x (Courtesy from Milella et al).261  
15. Figure 15: Implant samples in formalin at 1, 3, and 6 months postoperatively in the Cop 
alone group, the Cop-incorporating gelatine hydrogel group, and the Cop-incorporating 
gelatine hydrogel containing b-FGF group. (A), (D), (G): postoperative 1 month, (B) 
(E) (H): postoperative 3 months, (C) (F) (I): postoperative 6 months. After implantation 
of Cop alone (group A), the implanted copolymer became thicker than the original 
copolymer at one and three months after defect repair, but the thickness of the artificial 
implant was comparable to original copolymer as a result of degradation at 6 months 
postoperatively (A) (B) (C). After implantation of Cop-incorporating gelatine hydrogel 
(group B), the implanted copolymer became thicker than the original copolymer 1 
month postoperatively, but the thickness of the artificial implant was almost equal to 
that of the original copolymer through degradation at 6 months postoperatively (D) (E) 
(F). After implantation of Cop-incorporating gelatine hydrogel containing b-FGF 
(group C), the change of wall thickness after implantation with b-FGF was similar to 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3 
 
that without b-FGF (G) (H) (I). (Ref 286= Reused with permissions, Copyrights 
@Elsevier) 
 
16. Figure 16 (A) FOXJ1 (green) expressed in the native trachea (B) and isolated hPAECs. 
Cell nuclei are visualized with DAPI (blue). F-actin labels the cell cytoskeleton (red). 
(C) SEM image of hPAECs appended to PCL/G/DCN scaffold. (D) Triple-
immunofluorescence staining of hPAECs that was cultured for 7 days on the 
PCL/G/DCN matrix (FOXJ1 (green); F-actin (red); DAPI (blue)). (Ref=287 Reused with 
permissions, Copyright @ Elsevier) 
 
17. Figure 17: (a) The tissue-engineered PCL and PLGA constructs in the shape of a ring 
were harvested at two (2W) and four weeks (4W) of implantation (N, no cells; C, 
chondrocytes; B, bone marrow stem cells) (b) The degradation of the polymer scaffolds 
(n = 3) in vivo was measured by gel permeation chromatography. The degradation 
behavior was recorded as a percent of the starting molecular weight (Mw). The error 
bars represent the mean standard deviation (SD). (Ref 269 = Reused with permissions 
copyright@ Elsevier). 
 
18. Figure 18: Histology of the resected foam implants demonstrates that even after 6 
weeks of implantation, the foams have failed to become completely infiltrated by 
fibrovascular tissue from the surrounding tissue. However, the TIPS foams (a) revealed 
greater tissue infiltration (between arrows) compared with compression-molded foams 
(b), but this was dependent on the pore orientation of the foam (F) at the site of 
implantation (c), with the greatest extent of infiltration occurring along the axis of the 
pores (arrows). (d) Quantitative assessment of the implanted foams included measuring 
the area of granulation tissue (between arrows) surrounding the foam (F) and counting 
the number of blood vessels in the granulation tissue (arrow heads). [(a) TIPS foam + 
0% Bioglass® after 6 weeks of implantation (original magnification ×20); (b) 
compression-molded foam + 0% Bioglass® after 6 weeks of implantation (original 
magnification ×20); (c) TIPS foam + 0% Bioglass® after 1 week of implantation 
(original magnification ×100); (d) TIPS foam + 0.1% Bioglass® after 2 weeks of 
implantation (original magnification ×200).] (Ref 312 = Reused with permissions, 
Copyright © 2005 Wiley Periodicals, Inc). 
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